Phase II Study of 99mTc-glucarate in Chest Pain Patients Suspected With ACS With no Obvious Signs of AMI and With Known Previous CAD.

Trial Profile

Phase II Study of 99mTc-glucarate in Chest Pain Patients Suspected With ACS With no Obvious Signs of AMI and With Known Previous CAD.

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Sep 2016

At a glance

  • Drugs Tc 99m glucarate (Primary)
  • Indications Acute coronary syndromes
  • Focus Diagnostic use
  • Sponsors Molecular Targeting Technologies
  • Most Recent Events

    • 11 Jun 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top